<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the effect of <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B virus (HBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> on <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 1298 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients were recruited from January 2001 to March 2005 in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Enzyme-linked immunosorbent assay was used to test serum HBV markers for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were divided into study (<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>) group and control (non-<z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>) group </plain></SENT>
<SENT sid="4" pm="."><plain>Clinical features of patients in two groups were compared </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e> was found in 319 out of the 1298 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> was significantly lower in study group than in control group (14.2% vs 28.2%, P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>HBV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> significantly decreased the risk of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> [hazard ratio (HR): 0.50, 95% confidence interval (95% CI): 0.38-0.66], but the incidence of extrahepatic <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> was significantly higher in study group than in control group (31.9% vs 17.0%, P &lt; 0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>The HR was the lowest in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B group (HR: 0.29, 95% CI: 0.12-0.72) </plain></SENT>
<SENT sid="9" pm="."><plain>The number of liver metastatic lesions was significantly less in study group than in control group with a higher surgical resection rate </plain></SENT>
<SENT sid="10" pm="."><plain>However, no significant difference was found in survival rate between the two groups (P = 0.95) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: HBV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> decreases the risk of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and elevates the surgical resection rate of liver metastatic lesions </plain></SENT>
</text></document>